due to type 2 diabetes.". avapro and hairloss Engl J Med 345 (12): 851-60. PMID 11565517.^ Rossi S, editor. Australian Medicines avapro and hairloss 2006. ISBN 0-9757919-2-3 IrbesartanFrom Wikipedia, the free encyclopedia(Redirected from Avapro)Jump to: navigation, searchIrbesartanSystematic (IUPAC).

number 138402-11-6ATC code avapro and hairloss 3749DrugBank APRD00413Chemical dataFormula C25H28N6OMol. mass 428.53SMILES eMolecules & PubChemPharmacokinetic avapro and hairloss avapro and hairloss Hepatic (CYP2C9)Half life 11–15 hoursExcretion Renal 20%, faecal 65%Therapeutic considerationsLicence data EU, USPregnancy cat. D (Au)Legal status S4 (Au), POM (UK), ?-only (U.S.)Routes OralIrbesartan avapro and hairloss (pronounced /?rb??s?rt?n/) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. Irbesartan may also delay progression of diabetic nephropathy and is also indicated for avapro and hairloss treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of sanofi-aventis). It is jointly marketed by sanofi-aventis and Bristol-Myers Squibb under the trade names to irbesartan avapro and hairloss including CoAprovel, Karvezide, Avalide and Avapro HCT.[edit] References^ Lewis EJ, Hunsicker LG, Clarke avapro and hairloss Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC.

dataBioavailability 60–80%Metabolism Hepatic (CYP2C9)Half life 11–15 hoursExcretion Renal 20%, faecal.